8-K: Tevogen Bio Holdings Appoints KPMG as New Independent Auditor, Replacing Marcum LLP

Tevogen Bio Holdings Inc. has appointed KPMG as its new independent registered public accounting firm, replacing Marcum LLP, effective April 29, 2024.

Summary

• Tevogen Bio Holdings Inc. has changed its independent registered public accounting firm from Marcum LLP to KPMG LLP, effective April 29, 2024.
• The decision was approved by the audit committee of the Board of Directors.
• KPMG previously served as the independent auditor for Tevogen Bio Inc. before its merger with Tevogen Bio Holdings.
• Marcum's audit report for the fiscal years ended December 31, 2023 and 2022 included an explanatory paragraph about the company's ability to continue as a going concern.
• There were no disagreements between Tevogen and Marcum regarding accounting principles or auditing scope.
• Tevogen had previously disclosed a material weakness in internal control over financial reporting related to complex financial instruments and collectability of amounts due from related parties.

Sentiment

Score: 6

Explanation: The change in auditors is a neutral event, but the going concern note and material weakness in internal controls are concerning. The appointment of KPMG is a positive, but the overall sentiment is slightly cautious.

Positives

• The appointment of KPMG, a large and reputable firm, may provide investors with increased confidence in the company's financial reporting.
• There were no disagreements between the company and Marcum regarding accounting principles or auditing scope.

Negatives

• Marcum's audit report included an explanatory paragraph about the company's ability to continue as a going concern, which is a potential concern.
• The company previously disclosed a material weakness in internal control over financial reporting.

Risks

• The material weakness in internal control over financial reporting could lead to future issues with financial reporting.
• The going concern note in Marcum's audit report indicates potential financial instability.

Industry Context

The change in auditors is not uncommon after a merger or acquisition, as the new entity may want to consolidate its financial reporting under one firm. The appointment of a large firm like KPMG is often seen as a positive step for a company's credibility.

Comparison to Industry Standards

• Switching auditors is a common practice after a merger, and the appointment of a Big Four firm like KPMG is generally viewed positively.
• Many companies in the biotech sector use Big Four firms for their audits, including companies like Moderna and BioNTech.
• The going concern note from Marcum is not uncommon for early-stage biotech companies, but it is a point of concern that investors will monitor.

Stakeholder Impact

• Shareholders may view the change in auditors as a positive step, but will also be concerned about the going concern note and material weakness.
• The company's employees will need to adapt to the new auditor's processes.

Next Steps

• KPMG will conduct the audit for the fiscal year ending December 31, 2024.
• The company will need to address the material weakness in internal control over financial reporting.

Key Dates

Keywords

auditor, KPMG, Marcum, accounting, financial reporting, internal control, going concern, audit committee